Literature DB >> 11388505

Performance of the OptiMAL assay for detection and identification of malaria infections in asymptomatic residents of Irian Jaya, Indonesia.

D J Fryauff1, M A Sutamihardja, I R Elyazar, I Susanti, B Subianto, H Marwoto.   

Abstract

The OptiMAL assay, a new immunochromatographic "dipstick" test for malaria based on detection of Plasmodium lactate dehydrogenase (pLDH), is purported to detect infections of approximately 200 parasites/microL of blood and to differentiate between Plasmodium falciparum and non-P. falciparum. We evaluated OptiMAL performance by comparing the test strip interpretations of two independent readers with consensus results obtained independently by expert malaria microscopists. Unbiased measures of sensitivity were derived by applying the OptiMAL test for detection and differentiation of light, asymptomatic infections by P. falciparum and Plasmodium vivax. OptiMAL readings were separated in time to determine whether the reaction signal was stable. Microscopy identified infections in 225 of 505 individuals screened; those with P. falciparum (n = 170) averaged 354 asexual forms/microL and P. vivax/Plasmodium malariae (n = 112) averaged 216 asexual forms/microL of blood. Concordance between OptiMAL and microscopy was 81% and 78% by the two independent readings. The assay's sensitivity for detection of any malaria species was 60.4% and 70.2% respectively and specificity was 97% and 89%. Most cases identified by microscopy as P. falciparum were graded as negative or non-falciparum by both OptiMAL readers. OptiMAL false negatives as well as misidentifications were related to low parasitemias (< 500/microL). The OptiMAL assay demonstrated 88-92% sensitivity for detecting infections of 500-1,000 parasites/microL, a range covering the mean parasitemia of primary symptomatic P. falciparum infections in malaria-naïve Indonesian transmigrants. This device was markedly less sensitive than expert microscopy for discriminating between malaria species and is presently unsuited for use as an epidemiological screening tool. The OptiMAL assay is not approved for diagnostic use but is commercially available for research purposes only.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11388505     DOI: 10.4269/ajtmh.2000.63.139

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  11 in total

Review 1.  Rapid diagnostic tests for malaria parasites.

Authors:  Anthony Moody
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

Review 2.  Malaria distribution, prevalence, drug resistance and control in Indonesia.

Authors:  Iqbal R F Elyazar; Simon I Hay; J Kevin Baird
Journal:  Adv Parasitol       Date:  2011       Impact factor: 3.870

3.  Comparison of two commercial assays with expert microscopy for confirmation of symptomatically diagnosed malaria.

Authors:  Jamshaid Iqbal; Nabila Khalid; Parsotam R Hira
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

4.  Rapid diagnosis of vivax malaria by the SD Bioline Malaria Antigen test when thrombocytopenia is present.

Authors:  Sei Won Lee; Kyeongman Jeon; Byung Ryul Jeon; Inho Park
Journal:  J Clin Microbiol       Date:  2007-12-26       Impact factor: 5.948

5.  Sensitivity and specificity of isolated antigen fromPlasmodium falciparum culture supernatant.

Authors:  M M Mya; R K Saxena; Arati Roy
Journal:  Indian J Clin Biochem       Date:  2002-01

Review 6.  Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries.

Authors:  Katharine Abba; Jonathan J Deeks; Piero Olliaro; Cho-Min Naing; Sally M Jackson; Yemisi Takwoingi; Sarah Donegan; Paul Garner
Journal:  Cochrane Database Syst Rev       Date:  2011-07-06

Review 7.  Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries.

Authors:  Katharine Abba; Amanda J Kirkham; Piero L Olliaro; Jonathan J Deeks; Sarah Donegan; Paul Garner; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2014-12-18

8.  Use of a pLDH-based dipstick in the diagnostic and therapeutic follow-up of malaria patients in Mali.

Authors:  Amed Ouattara; Safiatou Doumbo; Renion Saye; Abdoul H Beavogui; Boubacar Traoré; Abdoulaye Djimdé; Amadou Niangaly; Kassoum Kayentao; Mouctar Diallo; Ogobara K Doumbo; Mahamadou A Thera
Journal:  Malar J       Date:  2011-11-24       Impact factor: 2.979

9.  Malaria rapid diagnostic test as point-of-care test: study protocol for evaluating the VIKIA Malaria Ag Pf/Pan.

Authors:  Saorin Kim; Sina Nhem; Dany Dourng; Didier Ménard
Journal:  Malar J       Date:  2015-03-14       Impact factor: 2.979

10.  Improving community health worker use of malaria rapid diagnostic tests in Zambia: package instructions, job aid and job aid-plus-training.

Authors:  Steven A Harvey; Larissa Jennings; Masela Chinyama; Fred Masaninga; Kurt Mulholland; David R Bell
Journal:  Malar J       Date:  2008-08-22       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.